Hydrochlorothiazide Capsule
Product Images NDC 57237-002

2 FDA label images from Rising Pharma Holdings, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydrochlorothiazide (NDC 57237-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (12.5 mg (100 Capsule Bottle))

Package Label-principal Display Panel (12.5 mg (100 Capsule Bottle))
Label of Hydrochlorothiazide Capsules USP 12.5 mg by Rising Pharma Holdings, Inc. The label states the dosage form as capsules, contains 100 capsules, and is for prescription use only. It includes storage instructions, distributor information (Rising Health, LLC, Saddle Brook, NJ), manufacturing origin (India), and a barcode.*
FDA Label Image

Chemical Structure (Hydrochloro Str)

Chemical Structure (Hydrochloro Str)
Chemical structure of Hydrochlorothiazide showing the molecular arrangement including sulfonamide groups, a chlorine atom, and a benzothiadiazine ring system.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.